Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer.
about
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.Biomedical applications of trastuzumab: as a therapeutic agent and a targeting ligand.Advantages and disadvantages of technologies for HER2 testing in breast cancer specimens.Comparison of HER2 testing among laboratories: Our experience with review cases retested at Moffitt Cancer Center in a two-year period.Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer.Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study.Bright-field microscopy for HER2 gene assessment: not just DISH-ful thinking?Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers.Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer: A Cohort Study Emphasizing Equivocal Cases.
P2860
Q35541778-C41F1DCF-0A77-4388-A3E4-B4422B33AC1BQ38408138-38F8501F-126D-4C39-AC3A-EE37DF3EED62Q38612634-4B672B24-4BE7-40F1-8118-231745B6AFE9Q38681307-39ACE5D4-76FB-4866-8461-89A2A8661320Q40338226-DF872BBE-B1F2-416D-B1FB-B9959394131BQ40453735-196689CF-A513-4906-BD27-D6D86DF816FEQ44958097-72A319AC-6D26-431F-AAD8-93B6D0287180Q51521953-EF05B59E-E0BA-4AD9-A3C7-83A9BD9F306FQ51560507-5DC7AA6B-B76E-4E45-8FD6-31E261B26D14
P2860
Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Comparison of fluorescence in ...... HER2 status in breast cancer.
@en
Comparison of fluorescence in situ hybridization
@nl
type
label
Comparison of fluorescence in ...... HER2 status in breast cancer.
@en
Comparison of fluorescence in situ hybridization
@nl
prefLabel
Comparison of fluorescence in ...... HER2 status in breast cancer.
@en
Comparison of fluorescence in situ hybridization
@nl
P2093
P2860
P356
P1476
Comparison of fluorescence in ...... HER2 status in breast cancer.
@en
P2093
Ahmet Dogan
Anne E Wiktor
Frank J Walsh
Jeanette E Eckel-Passow
Melissa Lonzo
Robert B Jenkins
William R Sukov
Yuta Sakai
P2860
P304
P356
10.1309/AJCP13GJAOJAYJMW
P407
P577
2013-02-01T00:00:00Z